We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002384:SZSESuzhou Dongshan Precision Manufacturing Co., Ltd. Analysis

Data as of 2026-07-17 - not real-time

CN¥241.92

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Suzhou Dongshan is trading at CNY 241.9, comfortably above its 20‑day SMA of ~250 and near the 52‑week high of 280, while the 50‑day SMA sits around 233, indicating a short‑term bullish bias. However, the MACD has turned bearish (line below signal) and the histogram is negative, suggesting weakening momentum, and the RSI hovers near 50, offering no clear over‑bought signal.
Fundamentally, the company posted a 52.7% revenue surge year‑over‑year, yet gross and operating margins remain modest (~14% and 13% respectively) and free cash flow is negative. The trailing P/E of 214x dwarfs the industry average of 33x, and the DCF‑derived fair value (~62) is far below the market price, flagging severe overvaluation. High leverage (debt‑to‑equity ~97) and a payout ratio of only 6% further question dividend sustainability.
Risk‑wise, the stock exhibits very high 30‑day volatility (~94%) and a beta close to 1, meaning it moves with the broader market but with amplified swings. The electronic components sector carries medium cyclical risk, while operating in China adds medium regulatory and geographic exposure. Strong trading volume and a market cap of CNY 443 bn keep liquidity risk low, but the financial profile raises concerns.
Given the blend of bullish technical backdrop, stark valuation disconnect, and financial strain, investors should tread cautiously, monitoring for any price correction or improvement in cash generation before committing capital.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD crossover
  • Price near resistance with limited upside
  • Severe overvaluation relative to DCF

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Robust revenue growth
  • High debt and negative free cash flow
  • Valuation still far above intrinsic estimates

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Exposure to high‑growth segments like new‑energy vehicles
  • Potential for margin improvement
  • Market correction could align price with fair value

Key Metrics & Analysis

Financial Health

Revenue Growth52.70%
Profit Margin4.57%
P/E Ratio214.1
ROE9.74%
ROA3.05%
Debt/Equity96.81
P/B Ratio19.4
Op. Cash FlowCN¥5.1B
Free Cash FlowCN¥-3227469824
Industry P/E32.8

Technical Analysis

TrendBullish
RSI49.7
SupportCN¥204.00
ResistanceCN¥280.08
MA 20CN¥250.21
MA 50CN¥233.23
MA 200CN¥127.28
MACDBearish
VolumeIncreasing
Fear & Greed Index87.91

Valuation

Fair ValueCN¥61.76
Target PriceCN¥188.00
Upside/Downside-22.29%
GradeOvervalued
TypeGrowth
Dividend Yield0.03%

Risk Assessment

Beta0.96
Volatility94.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.